# Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve

> **NCT03249272** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 31 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy
- Non-ischemic Dilated Cardiomyopathy
- Microvascular Ischaemia of Myocardium

## Interventions

- **DRUG:** Regadenoson
- **DRUG:** Adenosine

## Key facts

- **NCT ID:** NCT03249272
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-05
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Sponsor withdrew funding
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249272, "Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03249272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*